How should inconclusive results be managed in a drug testing laboratory?

How should inconclusive results be managed in a drug testing laboratory?

• A. They typically require recollection or additional testing per policy; avoid definitive positive/negative reporting without sufficient evidence.
• B. Report as negative to avoid delays.
• C. Report as positive to err on the side of safety.
• D. Discard the sample and request a new one without policy guidance.

Answer: (A)

Inconclusive results mean there isn’t enough evidence to determine a clear positive or negative outcome, often due to specimen issues, assay limitations, or data that cannot be interpreted reliably. The right path is to follow established policy and take steps to obtain a definitive result, typically by recollecting the specimen or performing additional testing. This approach protects accuracy and safety, ensuring that a final decision isn’t made on ambiguous data. It also preserves the integrity of the testing process by collecting a fresh sample if needed and by repeating appropriate assays or using a confirmatory method to resolve the ambiguity. Think of the alternatives as risking misclassification or unnecessary delays: reporting negative or positive without a solid basis can lead to incorrect decisions, and discarding the sample without guidance can create gaps in coverage or repeat testing requirements. By adhering to policy and pursuing recollection or further testing, the laboratory demonstrates due diligence, proper quality control, and proper chain-of-custody management while working toward a reliable final result.

Inconclusive results mean there isn’t enough evidence to determine a clear positive or negative outcome, often due to specimen issues, assay limitations, or data that cannot be interpreted reliably. The right path is to follow established policy and take steps to obtain a definitive result, typically by recollecting the specimen or performing additional testing. This approach protects accuracy and safety, ensuring that a final decision isn’t made on ambiguous data. It also preserves the integrity of the testing process by collecting a fresh sample if needed and by repeating appropriate assays or using a confirmatory method to resolve the ambiguity.

Think of the alternatives as risking misclassification or unnecessary delays: reporting negative or positive without a solid basis can lead to incorrect decisions, and discarding the sample without guidance can create gaps in coverage or repeat testing requirements. By adhering to policy and pursuing recollection or further testing, the laboratory demonstrates due diligence, proper quality control, and proper chain-of-custody management while working toward a reliable final result.